Statement Of Cash Flows

Fuji Pharma Co.,Ltd. - Filing #7364276

Concept As at
2023-09-30
2022-10-01 to
2023-09-30
2021-10-01 to
2022-09-30
As at
2022-09-30
As at
2021-09-30
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,887,000,000 JPY
878,000,000 JPY
Interest and dividends received
79,000,000 JPY
44,000,000 JPY
Interest paid
-104,000,000 JPY
-82,000,000 JPY
Income taxes paid
-946,000,000 JPY
-1,498,000,000 JPY
Net cash provided by (used in) operating activities
1,917,000,000 JPY
-658,000,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
-3,327,000,000 JPY
-5,097,000,000 JPY
Proceeds from sale of property, plant and equipment
10,000,000 JPY
1,383,000,000 JPY
Other, net
-111,000,000 JPY
-1,000,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-5,240,000,000 JPY
-11,271,000,000 JPY
Cash flows from financing activities
Dividends paid
-899,000,000 JPY
-729,000,000 JPY
Proceeds from issuance of bonds
2,985,000,000 JPY
JPY
Proceeds from long-term borrowings
JPY
7,300,000,000 JPY
Net cash provided by (used in) financing activities
1,915,000,000 JPY
5,094,000,000 JPY
Redemption of bonds
-300,000,000 JPY
JPY
Repayments of long-term borrowings
-2,440,000,000 JPY
-2,140,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
185,000,000 JPY
183,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,221,000,000 JPY
-6,653,000,000 JPY
Cash and cash equivalents
2,324,000,000 JPY
3,546,000,000 JPY
10,199,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.